Bradycardia due to remdesivir: Report of two cases.
作者信息
Cebrián Lara Laura, Hernàndez Lorente Eva, García Llopis Paula
机构信息
Servicio de Farmacia, Hospital Universitario de La Ribera, Alzira, Valencia, Spain.
出版信息
Med Clin (Engl Ed). 2022 Jan 21;158(2):94-95. doi: 10.1016/j.medcle.2021.03.030. Epub 2022 Jan 4.
Abstract
摘要
相似文献
1
Bradycardia due to remdesivir: Report of two cases.瑞德西韦导致的心动过缓：两例报告。
Med Clin (Engl Ed). 2022 Jan 21;158(2):94-95. doi: 10.1016/j.medcle.2021.03.030. Epub 2022 Jan 4.
2
Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review.瑞德西韦治疗新型冠状病毒肺炎相关窦性心动过缓：一例报告及文献综述
J Cardiovasc Dev Dis. 2021 Feb 12;8(2):18. doi: 10.3390/jcdd8020018.
3
Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?新型冠状病毒肺炎期间与瑞德西韦相关的心动过缓：持续性还是永久性？
Cureus. 2021 Nov 26;13(11):e19919. doi: 10.7759/cureus.19919. eCollection 2021 Nov.
4
Cardiac Adverse Events With Remdesivir in COVID-19 Infection.瑞德西韦治疗新型冠状病毒肺炎感染的心脏不良事件
Cureus. 2020 Oct 24;12(10):e11132. doi: 10.7759/cureus.11132.
5
Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.瑞德西韦治疗新型冠状病毒肺炎相关的显著窦性心动过缓：1例病例及文献综述
JACC Case Rep. 2020 Nov 18;2(14):2260-2264. doi: 10.1016/j.jaccas.2020.08.025. Epub 2020 Oct 28.
6
Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease.瑞德西韦治疗新型冠状病毒肺炎时诱发的症状性心动过缓。
HeartRhythm Case Rep. 2021 Aug;7(8):514-517. doi: 10.1016/j.hrcr.2021.05.004. Epub 2021 May 15.
7
Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report.瑞德西韦治疗中度至重度症状的COVID-19孕妇：系列病例报告
Infect Dis Rep. 2021 May 17;13(2):437-443. doi: 10.3390/idr13020042.
8
The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.2019新型冠状病毒感染的危重症产科患者成功应用恢复期血浆疗法和瑞德西韦治疗：一例病例报告
Case Rep Womens Health. 2020 May 16;27:e00221. doi: 10.1016/j.crwh.2020.e00221. eCollection 2020 Jul.
9
Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.新型冠状病毒肺炎（COVID-19）的肝脏表现及瑞德西韦对COVID-19患者肝功能的影响。
Proc (Bayl Univ Med Cent). 2021 Mar 8;34(4):473-477. doi: 10.1080/08998280.2021.1885289.
10
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System.瑞德西韦可能相关的心脏事件：来自欧洲自发不良事件报告系统的分析
Pharmaceuticals (Basel). 2021 Jun 25;14(7):611. doi: 10.3390/ph14070611.
引用本文的文献
1
Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project.通过美国食品和药物管理局美国医学毒理学学院 COVID-19 毒理学药物警戒项目鉴定瑞德西韦给药后的心动过缓。
JAMA Netw Open. 2023 Feb 1;6(2):e2255815. doi: 10.1001/jamanetworkopen.2022.55815.
Zotero 插件